Simvastatin

ras homolog family member A ; Homo sapiens







55 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35601076 Simvastatin alleviates epithelial-mesenchymal transition and oxidative stress of high glucose-induced lens epithelial cells in vitro by inhibiting RhoA/ROCK signaling. 2022 Jun 1
2 33897882 MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer. 2021 1
3 32210573 Simvastatin Inhibits the Malignant Behaviors of Gastric Cancer Cells by Simultaneously Suppressing YAP and β-Catenin Signaling. 2020 1
4 32694763 Author Correction: Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation. 2020 Jul 22 1
5 33597925 Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves' Ophthalmopathy-Derived Orbital Fibroblasts via RhoA-Mediated ERK and p38 Signaling Pathways. 2020 4
6 30872677 Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation. 2019 Mar 14 5
7 29319354 Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension. 2018 9
8 29604489 Attenuation of TNF-induced neutrophil adhesion by simvastatin is associated with the inhibition of Rho-GTPase activity, p50 activity and morphological changes. 2018 May 1
9 28344327 Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells. 2017 Mar 27 1
10 29039527 Simvastatin inhibits the expression of stemness‑related genes and the metastatic invasion of human cancer cells via destruction of the cytoskeleton. 2017 Dec 1
11 29236027 Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer. 2017 Dec 13 2
12 27180285 Simvastatin inhibits protein isoprenylation in the brain. 2016 Aug 4 1
13 26207907 Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition. 2015 2
14 26451103 Simvastatin enhances Rho/actin/cell rigidity pathway contributing to mesenchymal stem cells' osteogenic differentiation. 2015 3
15 24471776 Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts. 2014 Jan-Feb 2
16 24535918 RhoA-mediated inhibition of vascular endothelial cell mobility: positive feedback through reduced cytosolic p21 and p27. 2014 Oct 2
17 24582560 HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation. 2014 Mar 28 2
18 25023790 HMG-CoA reductase inhibition prior reperfusion improves reparative fibrosis post-myocardial infarction in a preclinical experimental model. 2014 Aug 20 1
19 22451024 Inhibitory effects of simvastatin on migration and invasion of rheumatoid fibroblast-like synoviocytes by preventing geranylgeranylation of RhoA. 2013 Feb 5
20 23424259 A transcriptomics-informed genetic association study identifies RHOA in simvastatin-induced low-density lipoprotein cholesterol lowering. 2013 Feb 1
21 23559002 Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases. 2013 Apr 4 4
22 22127053 Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells. 2012 Feb 29 2
23 23166513 RHOA is a modulator of the cholesterol-lowering effects of statin. 2012 1
24 20463291 The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle. 2011 Mar 2
25 20473500 HMG-CoA reductase inhibitor simvastatin suppresses Toll-like receptor 2 ligand-induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients. 2011 Nov 4
26 21052011 Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway. 2011 Feb 3
27 21844074 Donor simvastatin treatment abolishes rat cardiac allograft ischemia/reperfusion injury and chronic rejection through microvascular protection. 2011 Sep 6 2
28 19786891 Inhibitory effects of simvastatin on platelet-derived growth factor signaling in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. 2010 Jan 1
29 20378830 3-Hydroxymethyl coenzyme A reductase inhibition attenuates spontaneous smooth muscle tone via RhoA/ROCK pathway regulated by RhoA prenylation. 2010 Jun 3
30 19001041 Blunted Akt/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy. 2009 Jan 15 2
31 17452038 Pharmacological inhibition of RhoA signaling prevents connective tissue growth factor induction in endothelial cells exposed to non-uniform shear stress. 2008 Jan 1
32 18199714 Statin induces apoptosis and cell growth arrest in prostate cancer cells. 2008 Jan 1
33 18356691 Simvastatin stimulates vascular endothelial growth factor production by hypoxia-inducible factor-1alpha upregulation in endothelial cells. 2008 Mar 1
34 18463201 Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells. 2008 Aug 1
35 18619957 Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells. 2008 Sep 4 2
36 18625202 HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway. 2008 Sep 19 2
37 18658277 Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition. 2008 Oct 1
38 18981156 Induction of scavenger receptor class B type I is critical for simvastatin enhancement of high-density lipoprotein-induced anti-inflammatory actions in endothelial cells. 2008 Nov 15 1
39 17217948 Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells. 2007 Mar 1
40 16740276 Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA. 2006 Sep 5 4
41 16774905 HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation. 2006 Nov 2
42 16775505 Statins blunt thrombin-induced down-regulation of endothelial nitric oxide synthase expression in human endothelial cells. 2006 May 1
43 16858009 Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin. 2006 Dec 7
44 17075836 RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin. 2006 Nov 2
45 17237547 Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis. 2006 4
46 15728660 Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels. 2005 May 2
47 14985071 Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. 2004 Mar 1 3
48 15339992 RhoA activation mediates phosphatidylinositol 3-kinase-dependent proliferation of human vascular endothelial cells: an alloimmune mechanism of chronic allograft nephropathy. 2004 Sep 2
49 12477733 Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients. 2003 Feb 21 1
50 12951326 Modulation of the expression of connective tissue growth factor by alterations of the cytoskeleton. 2003 Nov 7 1